Fraudsters will invest heavily in fake COVID-19 vaccine: Europol
01-05-2020
OECD and Europol issue COVID-19 counterfeits warning
22-04-2020
VonaUA / Shutterstock.com
Companies registered in the US are hit hardest by the trade in counterfeit medicines, which in 2016 reached $4.4 billion, according to a report from the European Union Intellectual Property Office (EUIPO).
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
EUIPO, OECD, counterfeit medicines, counterfeit trade, drugs, trade, pharmaceutical products, Christian Archambeau
